Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer (Q35867858)

10 August 2017

title

Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer (English)

1 reference

10 August 2017

0 references

Cheng Wu

1

1 reference

10 August 2017

Zhiwen Luo

2

1 reference

10 August 2017

Dan Tang

3

1 reference

10 August 2017

Lijie Liu

4

1 reference

10 August 2017

Dingkang Yao

5

1 reference

10 August 2017

Liang Zhu

6

1 reference

10 August 2017

Zhiqiang Wang

7

1 reference

10 August 2017

publication date

11 December 2015

1 reference

10 August 2017

1 reference

10 August 2017

volume

37

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

6963-6970

1 reference

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Update on metastatic gastric and esophageal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Gastric cancer: prevention, screening and early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Implementation of gastric cancer screening - the global experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Proteomics in pathology, research and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Integrated microanalytical technology enabling rapid and automated protein identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

MALDI-TOF MS as evolving cancer diagnostic tool: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

The identification and characterization of novel N-glycan-based biomarkers in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

The thrombophilic state in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Identification of the thrombin light chain a as the single best mass for differentiation of gastric cancer patients from individuals with dyspepsia by proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Diagnosis of gastric cancer using decision tree classification of mass spectral data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S13277-015-4394-Y

Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis

21 January 2018

1 reference

12 December 2020

A genomic approach to investigate expression profiles in Slovenian patients with gastric cancer

1 reference

12 December 2020

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

1 reference

12 December 2020

Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology

1 reference

12 December 2020

Screening and identification of serum proteomic biomarkers for gastric adenocarcinoma

1 reference

12 December 2020

Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry

1 reference

12 December 2020

10.1007/S13277-015-4394-Y

Identifiers

DOI

1 reference

10 August 2017

1 reference